Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Bradley Allen Maron, M.D.

Title
Institution
Department
Address
Phone
Fax

Mentoring
current student opportunities
Available: 04/05/22, Expires: 06/01/23

We use network medicine, in vitro systems, and in vivo models to test hypothesis that identify potential therapeutic targets. These data are validated in tissue from patients.


Research
research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
Most Recent  |  List All
  1. 5R01HL163960-02 (BRITTAIN, EVAN/HEMNES, ANNA/MARON, BRADLEY) May 1, 2022 - Apr 30, 2027
    NIH
    Network Medicine and Systems Pharmacology to Advance Precision Medicine in Combined Pulmonary Hypertension
    Role: Co-Principal Investigator
  2. R01HL155096 (MARON, BRADLEY) Feb 1, 2021 - Jan 31, 2025
    NIH
    Personalized protein-protein interactomes and precision medicine in pulmonary arterial hypertension
    Role: Principal Investigator
  3. R01HL153502 (MARON, BRADLEY) Jun 1, 2020 - May 31, 2024
    NIH
    NEDD9-SMAD3, fibrinolysis, and chronic thromboembolic pulmonary hypertension
    Role: Principal Investigator
  4. R21HL145420 (MARON, BRADLEY) Feb 1, 2019 - Jan 31, 2021
    NIH
    Network medicine, risk stratification, and pulmonary hypertension
    Role: Principal Investigator
  5. R01HL139613 (MARON, BRADLEY) Jan 1, 2018 - Dec 31, 2021
    NIH
    Systems biology, endothelial regulation of fibrosis, and pulmonary vascular disease
    Role: Principal Investigator

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Wertheim BM, Wang RS, Guillermier C, Hütter CV, Oldham WM, Menche J, Steinhauser ML, Maron BA. Proline and glucose metabolic reprogramming supports vascular endothelial and medial biomass in pulmonary arterial hypertension. JCI Insight. 2023 Feb 22; 8(4). PMID: 36626231; PMCID: PMC9977503.
    Citations:    Fields:    Translation:HumansCells
  2. Wang RS, Maron BA, Loscalzo J. Multiomics Network Medicine Approaches to Precision Medicine and Therapeutics in Cardiovascular Diseases. Arterioscler Thromb Vasc Biol. 2023 Feb 16. PMID: 36794589.
    Citations:    Fields:    
  3. Kheyfets VO, Sweatt AJ, Gomberg-Maitland M, Ivy DD, Condliffe R, Kiely DG, Lawrie A, Maron BA, Zamanian RT, Stenmark KR. Computational platform for doctor-artificial intelligence cooperation in pulmonary arterial hypertension prognostication: a pilot study. ERJ Open Res. 2023 Jan; 9(1). PMID: 36776484; PMCID: PMC9907150.
    Citations:    
  4. Chouvarine P, Hysko K, Chan SY, Oliveira P, Maron BA, Kourembanas S, Hansmann G. Second International Pulmonary Hypertension/Heart Failure Symposium-Structural heart disease, right ventricular dysfunction, and stem cell therapy: The European Pediatric Pulmonary Vascular Disease Network. Pulm Circ. 2023 Jan; 13(1):e12175. PMID: 36628260; PMCID: PMC9826951.
    Citations: 1     
  5. Benincasa G, Napoli C, Loscalzo J, Maron BA. Pursuing functional biomarkers in complex disease: Focus on pulmonary arterial hypertension. Am Heart J. 2022 Dec 22; 258:96-113. PMID: 36565787.
    Citations:    Fields:    
  6. Maron BA, Wang RS, Shevtsov S, Drakos SG, Arons E, Wever-Pinzon O, Huggins GS, Samokhin AO, Oldham WM, Aguib Y, Yacoub MH, Rowin EJ, Maron BJ, Maron MS, Loscalzo J. Author Correction: Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes. Nat Commun. 2022 Nov 17; 13(1):7026. PMID: 36396654; PMCID: PMC9672304.
    Citations:    Fields:    
  7. Maron BA, Kleiner DE, Arons E, Wertheim BM, Sharma NS, Haley KJ, Samokhin AO, Rowin EJ, Maron MS, Rosing DR, Maron BJ. Evidence of Advanced Pulmonary Vascular Remodeling in Obstructive Hypertrophic Cardiomyopathy With Pulmonary Hypertension. Chest. 2022 Oct 13. PMID: 36243062.
    Citations:    Fields:    
  8. Zeder K, Banfi C, Steinrisser-Allex G, Maron BA, Humbert M, Lewis GD, Berghold A, Olschewski H, Kovacs G. Diagnostic, prognostic and differential-diagnostic relevance of pulmonary haemodynamic parameters during exercise: a systematic review. Eur Respir J. 2022 10; 60(4). PMID: 35332069; PMCID: PMC9556812.
    Citations:    Fields:    
  9. Gillmeyer KR, Rinne ST, Qian SX, Maron BA, Johnson SW, Klings ES, Wiener RS. Socioeconomically disadvantaged veterans experience treatment delays for pulmonary arterial hypertension. Pulm Circ. 2022 Oct; 12(4):e12171. PMID: 36568691; PMCID: PMC9768567.
    Citations:    
  10. Lippmann MR, Maron BA. The Right Ventricle: From Embryologic Development to RV Failure. Curr Heart Fail Rep. 2022 10; 19(5):325-333. PMID: 36149589; PMCID: PMC9818027.
    Citations:    Fields:    Translation:Humans
  11. Hemnes AR, Leopold JA, Radeva MK, Beck GJ, Abidov A, Aldred MA, Barnard J, Rosenzweig EB, Borlaug BA, Chung WK, Comhair SAA, Desai AA, Dubrock HM, Erzurum SC, Finet JE, Frantz RP, Garcia JGN, Geraci MW, Gray MP, Grunig G, Hassoun PM, Highland KB, Hill NS, Hu B, Kwon DH, Jacob MS, Jellis CL, Larive AB, Lempel JK, Maron BA, Mathai SC, McCarthy K, Mehra R, Nawabit R, Newman JH, Olman MA, Park MM, Ramos JA, Renapurkar RD, Rischard FP, Sherer SG, Tang WHW, Thomas JD, Vanderpool RR, Waxman AB, Wilcox JD, Yuan JX, Horn EM. Clinical Characteristics and Transplant-Free Survival Across the Spectrum of Pulmonary Vascular Disease. J Am Coll Cardiol. 2022 08 16; 80(7):697-718. PMID: 35953136; PMCID: PMC9897285.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  12. Benincasa G, Maron BA, Affinito O, D'Alto M, Franzese M, Argiento P, Schiano C, Romeo E, Bontempo P, Golino P, Berrino L, Loscalzo J, Napoli C. Association Between Circulating CD4+ T Cell Methylation Signatures of Network-Oriented SOCS3 Gene and Hemodynamics in Patients Suffering Pulmonary Arterial Hypertension. J Cardiovasc Transl Res. 2023 Feb; 16(1):17-30. PMID: 35960497; PMCID: PMC9944731.
    Citations: 1     Fields:    Translation:HumansCells
  13. Maron BA, Wang RS, Carnethon MR, Rowin EJ, Loscalzo J, Maron BJ, Maron MS. What Causes Hypertrophic Cardiomyopathy? Am J Cardiol. 2022 09 15; 179:74-82. PMID: 35843734.
    Citations:    Fields:    
  14. Brittain EL, Thenappan T, Huston JH, Agrawal V, Lai YC, Dixon D, Ryan JJ, Lewis EF, Redfield MM, Shah SJ, Maron BA. Elucidating the Clinical Implications and Pathophysiology of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Call to Action: A Science Advisory From the American Heart Association. Circulation. 2022 08 16; 146(7):e73-e88. PMID: 35862198; PMCID: PMC9901193.
    Citations:    Fields:    
  15. Johnson SW, Finlay L, Mathai SC, Goldstein RH, Maron BA. Real-world use of inhaled treprostinil for lung disease-pulmonary hypertension: A protocol for patient evaluation and prescribing. Pulm Circ. 2022 Jul; 12(3):e12126. PMID: 36092795; PMCID: PMC9450844.
    Citations:    
  16. Johnson SW, Gillmeyer KR, Bolton RE, McCullough MB, Qian SX, Maron BA, Klings ES, Wiener RS. Variable Monitoring of Veterans with Group 3 Pulmonary Hypertension Treated with Off-Label Pulmonary Vasodilator Therapy. Ann Am Thorac Soc. 2022 07; 19(7):1236-1239. PMID: 35312466; PMCID: PMC9278628.
    Citations:    Fields:    Translation:Humans
  17. Jellis CL, Park MM, Abidov A, Borlaug BA, Brittain EL, Frantz R, Hassoun PM, Horn EM, Jaber WA, Jiwon K, Karas MG, Kwon D, Leopold JA, Maron B, Mathai SC, Mehra R, Rischard F, Rosenzweig EB, Tang WHW, Vanderpool R, Thomas JD. Comprehensive echocardiographic evaluation of the right heart in patients with pulmonary vascular diseases: the PVDOMICS experience. Eur Heart J Cardiovasc Imaging. 2022 06 21; 23(7):958-969. PMID: 34097027; PMCID: PMC9212349.
    Citations:    Fields:    Translation:Humans
  18. Maron BA, Humbert M. HFp2EF: heart failure with pulmonary dysfunction and preserved ejection fraction? Eur Heart J. 2022 06 14; 43(23):2209-2211. PMID: 35466998.
    Citations:    Fields:    Translation:Humans
  19. Alba GA, Samokhin AO, Wang RS, Wertheim BM, Haley KJ, Padera RF, Vargas SO, Rosas IO, Hariri LP, Shih A, Thompson BT, Mitchell RN, Maron BA. Pulmonary endothelial NEDD9 and the prothrombotic pathophenotype of acute respiratory distress syndrome due to SARS-CoV-2 infection. Pulm Circ. 2022 Apr; 12(2):e12071. PMID: 35599981; PMCID: PMC9111030.
    Citations: 2     
  20. Rhodes CJ, Sweatt AJ, Maron BA. Harnessing Big Data to Advance Treatment and Understanding of Pulmonary Hypertension. Circ Res. 2022 04 29; 130(9):1423-1444. PMID: 35482840; PMCID: PMC9070103.
    Citations:    Fields:    Translation:Humans
  21. Maron BA, Humbert M. Finding Pulmonary Arterial Hypertension-Switching to Offense to Mitigate Disease Burden. JAMA Cardiol. 2022 04 01; 7(4):369-370. PMID: 35234810; PMCID: PMC9040384.
    Citations:    Fields:    Translation:Humans
  22. Maron BA, Choudhary G, Goldstein RL, Garshick E, Jankowich M, Tucker TJS, LaCerda KA, Hattler B, Dempsey EC, Sadikot RT, Shapiro S, Rounds SI, Goldstein RH. Tadalafil for veterans with chronic obstructive pulmonary disease-pulmonary hypertension: A multicenter, placebo-controlled randomized trial. Pulm Circ. 2022 Jan; 12(1):e12043. PMID: 35506072; PMCID: PMC9053004.
    Citations: 1     
  23. Johnson SW, Maron BA. COUNTERPOINT: Did the World Symposium on Pulmonary Hypertension Get It Right in Redefining Abnormal Pulmonary Arterial Pressure? No. Chest. 2022 02; 161(2):313-315. PMID: 35131055.
    Citations:    Fields:    Translation:Humans
  24. Johnson SW, Maron BA. Rebuttal From Drs Johnson and Maron. Chest. 2022 02; 161(2):316-317. PMID: 35131057.
    Citations:    Fields:    
  25. Kovacs G, Maron BA. The assessment of pulmonary arterial pressure and its clinical relevance: a 100-year journey from Europe, over the United States to Australia. Eur Respir J. 2022 01; 59(1). PMID: 34972686.
    Citations:    Fields:    Translation:Humans
  26. Gong J, Castro RRT, Caron JP, Bay CP, Hainer J, Opotowsky AR, Mehra MR, Maron BA, Di Carli MF, Groarke JD, Nohria A. Usefulness of ventilatory inefficiency in predicting prognosis across the heart failure spectrum. ESC Heart Fail. 2022 02; 9(1):293-302. PMID: 34931762; PMCID: PMC8788025.
    Citations: 1     Fields:    Translation:Humans
  27. Maron BJ, Maron MS, Maurer MS, Rowin EJ, Maron BA, Galiè N. Cardiovascular Diseases That Have Emerged From the Darkness. J Am Heart Assoc. 2021 10 19; 10(20):e021095. PMID: 34622668; PMCID: PMC8751898.
    Citations:    Fields:    Translation:Humans
  28. Ruetzler K, Smilowitz NR, Berger JS, Devereaux PJ, Maron BA, Newby LK, de Jesus Perez V, Sessler DI, Wijeysundera DN. Diagnosis and Management of Patients With Myocardial Injury After Noncardiac Surgery: A Scientific Statement From the American Heart Association. Circulation. 2021 11 09; 144(19):e287-e305. PMID: 34601955.
    Citations: 3     Fields:    Translation:Humans
  29. Lee LY, Pandey AK, Maron BA, Loscalzo J. Network medicine in Cardiovascular Research. Cardiovasc Res. 2021 08 29; 117(10):2186-2202. PMID: 33165538; PMCID: PMC8404464.
    Citations: 7     Fields:    Translation:HumansAnimalsCells
  30. Zeder K, Avian A, Bachmaier G, Douschan P, Foris V, Sassmann T, Troester N, Brcic L, Fuchsjaeger M, Marsh LM, Maron BA, Olschewski H, Kovacs G. Elevated pulmonary vascular resistance predicts mortality in COPD patients. Eur Respir J. 2021 08; 58(2). PMID: 33986032.
    Citations: 4     Fields:    Translation:Humans
  31. Alba GA, Atri D, Darbha S, Singh I, Tapson VF, Lewis MI, Chun HJ, Yu YR, Maron BA, Rajagopal S. Chronic Thromboembolic Pulmonary Hypertension: the Bench. Curr Cardiol Rep. 2021 08 19; 23(10):141. PMID: 34410515.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  32. Matusov Y, Singh I, Yu YR, Chun HJ, Maron BA, Tapson VF, Lewis MI, Rajagopal S. Chronic Thromboembolic Pulmonary Hypertension: the Bedside. Curr Cardiol Rep. 2021 08 19; 23(10):147. PMID: 34410530; PMCID: PMC8375459.
    Citations:    Fields:    Translation:Humans
  33. Oldham WM, Hess E, Waldo SW, Humbert M, Choudhary G, Maron BA. Integrating haemodynamics identifies an extreme pulmonary hypertension phenotype. Eur Respir J. 2021 08; 58(2). PMID: 33833034; PMCID: PMC8529828.
    Citations: 2     Fields:    Translation:Humans
  34. Jankowich M, Maron BA, Choudhary G. Mildly elevated pulmonary artery systolic pressure on echocardiography: bridging the gap in current guidelines. Lancet Respir Med. 2021 10; 9(10):1185-1191. PMID: 34270923; PMCID: PMC8936511.
    Citations:    Fields:    Translation:Humans
  35. Rahaghi FN, Nardelli P, Harder E, Singh I, Sánchez-Ferrero GV, Ross JC, San José Estépar R, Ash SY, Hunsaker AR, Maron BA, Leopold JA, Waxman AB, San José Estépar R, Washko GR. Quantification of Arterial and Venous Morphologic Markers in Pulmonary Arterial Hypertension Using CT Imaging. Chest. 2021 12; 160(6):2220-2231. PMID: 34270966; PMCID: PMC8692106.
    Citations: 2     Fields:    Translation:Humans
  36. Maron BA, Abman SH, Elliott CG, Frantz RP, Hopper RK, Horn EM, Nicolls MR, Shlobin OA, Shah SJ, Kovacs G, Olschewski H, Rosenzweig EB. Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances. Am J Respir Crit Care Med. 2021 06 15; 203(12):1472-1487. PMID: 33861689; PMCID: PMC8483220.
    Citations: 8     Fields:    Translation:Humans
  37. Alba GA, Samokhin AO, Wang RS, Zhang YY, Wertheim BM, Arons E, Greenfield EA, Lundberg Slingsby MH, Ceglowski JR, Haley KJ, Bowman FP, Yu YR, Haney JC, Eng G, Mitchell RN, Sheets A, Vargas SO, Seo S, Channick RN, Leary PJ, Rajagopal S, Loscalzo J, Battinelli EM, Maron BA. NEDD9 Is a Novel and Modifiable Mediator of Platelet-Endothelial Adhesion in the Pulmonary Circulation. Am J Respir Crit Care Med. 2021 06 15; 203(12):1533-1545. PMID: 33523764; PMCID: PMC8483217.
    Citations: 5     Fields:    Translation:HumansAnimalsCells
  38. Leopold JA, Kawut SM, Aldred MA, Archer SL, Benza RL, Bristow MR, Brittain EL, Chesler N, DeMan FS, Erzurum SC, Gladwin MT, Hassoun PM, Hemnes AR, Lahm T, Lima JAC, Loscalzo J, Maron BA, Rosa LM, Newman JH, Redline S, Rich S, Rischard F, Sugeng L, Tang WHW, Tedford RJ, Tsai EJ, Ventetuolo CE, Zhou Y, Aggarwal NR, Xiao L. Diagnosis and Treatment of Right Heart Failure in Pulmonary Vascular Diseases: A National Heart, Lung, and Blood Institute Workshop. Circ Heart Fail. 2021 06; 14(6). PMID: 34422205; PMCID: PMC8375628.
    Citations: 1     Fields:    Translation:Humans
  39. Huston JH, Maron BA. Adjusting to the New Normal: Echocardiography to Find Pulmonary Hypertension. EClinicalMedicine. 2021 May; 35:100867. PMID: 34027329; PMCID: PMC8121989.
    Citations:    
  40. Gillmeyer KR, Miller DR, Glickman ME, Qian SX, Klings ES, Maron BA, Hanlon JT, Rinne ST, Wiener RS. Outcomes of pulmonary vasodilator use in Veterans with pulmonary hypertension associated with left heart disease and lung disease. Pulm Circ. 2021 Apr-Jun; 11(2):20458940211001714. PMID: 33868640.
    Citations: 1     
  41. Sarno F, Benincasa G, List M, Barabasi AL, Baumbach J, Ciardiello F, Filetti S, Glass K, Loscalzo J, Marchese C, Maron BA, Paci P, Parini P, Petrillo E, Silverman EK, Verrienti A, Altucci L, Napoli C. Clinical epigenetics settings for cancer and cardiovascular diseases: real-life applications of network medicine at the bedside. Clin Epigenetics. 2021 03 30; 13(1):66. PMID: 33785068; PMCID: PMC8010949.
    Citations: 3     Fields:    Translation:Humans
  42. Dezfulian C, Orkin AM, Maron BA, Elmer J, Girotra S, Gladwin MT, Merchant RM, Panchal AR, Perman SM, Starks MA, van Diepen S, Lavonas EJ. Opioid-Associated Out-of-Hospital Cardiac Arrest: Distinctive Clinical Features and Implications for Health Care and Public Responses: A Scientific Statement From the American Heart Association. Circulation. 2021 04 20; 143(16):e836-e870. PMID: 33682423.
    Citations: 4     Fields:    Translation:Humans
  43. Maron BA, Wang RS, Shevtsov S, Drakos SG, Arons E, Wever-Pinzon O, Huggins GS, Samokhin AO, Oldham WM, Aguib Y, Yacoub MH, Rowin EJ, Maron BJ, Maron MS, Loscalzo J. Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes. Nat Commun. 2021 02 08; 12(1):873. PMID: 33558530; PMCID: PMC7870822.
    Citations: 11     Fields:    Translation:HumansCells
  44. Maron BA, Kovacs G, Vaidya A, Bhatt DL, Nishimura RA, Mak S, Guazzi M, Tedford RJ. Cardiopulmonary Hemodynamics in Pulmonary Hypertension and Heart Failure: JACC Review Topic of the Week. J Am Coll Cardiol. 2020 12 01; 76(22):2671-2681. PMID: 33243385; PMCID: PMC7703679.
    Citations: 10     Fields:    Translation:Humans
  45. Clark K, Goldstein R, Maron B, Breu AC. A Veteran Presenting With Chronic Progressive Dyspnea on Exertion. Fed Pract. 2020 Nov; 37(11):522-526. PMID: 33328718.
    Citations:    
  46. Ryan JJ, Maron BA. Vericiguat in Heart Failure with Reduced Ejection Fraction. N Engl J Med. 2020 10 08; 383(15):1497. PMID: 33027578.
    Citations: 2     Fields:    Translation:Humans
  47. Lahm T, Hess E, Barón AE, Maddox TM, Plomondon ME, Choudhary G, Maron BA, Zamanian RT, Leary PJ. Renin-Angiotensin-Aldosterone System Inhibitor Use and Mortality in Pulmonary Hypertension: Insights From the Veterans Affairs Clinical Assessment Reporting and Tracking Database. Chest. 2021 04; 159(4):1586-1597. PMID: 33031831; PMCID: PMC8173779.
    Citations: 5     Fields:    Translation:Humans
  48. Viray MC, Bonno EL, Gabrielle ND, Maron BA, Atkins J, Amoroso NS, Fernandes VLC, Maran A, Nielsen CD, Powers ER, Steinberg DH, Todoran TM, Di Salvo TG, Jackson GR, Houston BA, Tedford RJ. Role of Pulmonary Artery Wedge Pressure Saturation During Right Heart Catheterization: A Prospective Study. Circ Heart Fail. 2020 11; 13(11):e007981. PMID: 33016102.
    Citations: 4     Fields:    Translation:Humans
  49. Sanders JL, Koestenberger M, Rosenkranz S, Maron BA. Right ventricular dysfunction and long-term risk of death. Cardiovasc Diagn Ther. 2020 Oct; 10(5):1646-1658. PMID: 33224778.
    Citations: 3     
  50. Hansmann G, Rich S, Maron BA. Cardiac catheterization in pulmonary hypertension: doing it right, with a catheter on the left. Cardiovasc Diagn Ther. 2020 Oct; 10(5):1718-1724. PMID: 33224785.
    Citations: 1     
  51. Ong MS, Klann JG, Lin KJ, Maron BA, Murphy SN, Natter MD, Mandl KD. Claims-Based Algorithms for Identifying Patients With Pulmonary Hypertension: A Comparison of Decision Rules and Machine-Learning Approaches. J Am Heart Assoc. 2020 10 20; 9(19):e016648. PMID: 32990147.
    Citations: 6     Fields:    Translation:Humans
  52. Macías CG, Wharam JF, Maron BA, Ong MS. Urban-Rural Disparities in Pulmonary Hypertension Mortality. Ann Am Thorac Soc. 2020 09; 17(9):1168-1171. PMID: 32584607.
    Citations: 1     Fields:    Translation:Humans
  53. Maron BA, Altucci L, Balligand JL, Baumbach J, Ferdinandy P, Filetti S, Parini P, Petrillo E, Silverman EK, Barabási AL, Loscalzo J. A global network for network medicine. NPJ Syst Biol Appl. 2020 08 31; 6(1):29. PMID: 32868765.
    Citations: 7     Fields:    Translation:Humans
  54. Maron BA. Clarifying the Pulmonary Arterial Hypertension Molecular Landscape Using Functional Genetics. Am J Respir Crit Care Med. 2020 08 15; 202(4):488-490. PMID: 32453600; PMCID: PMC7427395.
    Citations: 3     Fields:    Translation:Humans
  55. Maron BA, Brittain EL, Hess E, Waldo SW, Barón AE, Huang S, Goldstein RH, Assad T, Wertheim BM, Alba GA, Leopold JA, Olschewski H, Galiè N, Simonneau G, Kovacs G, Tedford RJ, Humbert M, Choudhary G. Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study. Lancet Respir Med. 2020 09; 8(9):873-884. PMID: 32730752; PMCID: PMC8219057.
    Citations: 25     Fields:    Translation:Humans
  56. Maron BA, Humbert M. Adding an important piece to the pulmonary vascular resistance puzzle in pulmonary arterial hypertension. Eur Respir J. 2020 07; 56(1). PMID: 32646896.
    Citations: 1     Fields:    Translation:Humans
  57. Maron BA, Gladwin MT, Bonnet S, De Jesus Perez V, Perman SM, Yu PB, Ichinose F. Perspectives on Cardiopulmonary Critical Care for Patients With COVID-19: From Members of the American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation. J Am Heart Assoc. 2020 07 21; 9(14):e017111. PMID: 32552164.
    Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
  58. Gillmeyer KR, Rinne ST, Glickman ME, Lee KM, Shao Q, Qian SX, Klings ES, Maron BA, Hanlon JT, Miller DR, Wiener RS. Factors Associated With Potentially Inappropriate Phosphodiesterase-5 Inhibitor Use for Pulmonary Hypertension in the United States, 2006 to 2015. Circ Cardiovasc Qual Outcomes. 2020 05; 13(5):e005993. PMID: 32393128.
    Citations: 2     Fields:    Translation:Humans
  59. Maron BA. Pulmonary arterial hypertension: Cellular and molecular changes in the lung. Glob Cardiol Sci Pract. 2020 Apr 30; 2020(1):e202003. PMID: 33150148.
    Citations:    
  60. Maron BA. Pulmonary arterial hypertension: Rationale for using multiple vs. single drug therapy. Glob Cardiol Sci Pract. 2020 Apr 30; 2020(1):e202008. PMID: 33150152.
    Citations:    
  61. Frid MG, Thurman JM, Hansen KC, Maron BA, Stenmark KR. Inflammation, immunity, and vascular remodeling in pulmonary hypertension; Evidence for complement involvement? Glob Cardiol Sci Pract. 2020 Apr 30; 2020(1):e202001. PMID: 32478115.
    Citations: 10     
  62. Butrous G, Maron B, Yacoub M. The lamp of medicine of Ancient Egypt is still burning. Glob Cardiol Sci Pract. 2020 Apr 30; 2020(1):e202016. PMID: 33150160.
    Citations: 1     
  63. Maron BA, Maron JL, Abman SH. The Case for Bringing Birthweight to Adult Cardiovascular Medicine. Am J Cardiol. 2020 07 15; 127:191-192. PMID: 32402484; PMCID: PMC8211405.
    Citations: 5     Fields:    Translation:Humans
  64. Parini P, Altucci L, Balligand JL, Baumbach J, Ferdinandy P, Filetti S, Maron BA, Petrillo E, Silverman EK, Barabasi AL, Loscalzo J. The Network Medicine Imperative and the Need for an International Network Medicine Consortium. Am J Med. 2020 09; 133(9):e451-e454. PMID: 32320696.
    Citations: 3     Fields:    Translation:Humans
  65. Rayner SG, Maron BA, Leary PJ. In reply, endothelin-1 and the Anrep effect. J Heart Lung Transplant. 2020 08; 39(8):847. PMID: 32303397.
    Citations:    Fields:    Translation:Humans
  66. Maron BA. Rebuttal From Dr Maron. Chest. 2020 04; 157(4):769-770. PMID: 32252928.
    Citations:    Fields:    Translation:Humans
  67. Maron BA. POINT: Should the New Definition of PH Be the Clinical Practice Standard? Yes. Chest. 2020 04; 157(4):764-766. PMID: 32252925.
    Citations: 1     Fields:    Translation:Humans
  68. Kurnat-Thoma E, Baranova A, Baird P, Brodsky E, Butte AJ, Cheema AK, Cheng F, Dutta S, Grant C, Giordano J, Maitland-van der Zee AH, Fridsma DB, Jarrin R, Kann MG, Keeney J, Loscalzo J, Madhavan G, Maron BA, McBride DK, McKean M, Mun SK, Palmer JC, Patel B, Parakh K, Pariser AR, Pristipino C, Radstake TRDJ, Rajasimha HK, Rouse WB, Rozman D, Saleh A, Schmidt HHHW, Schultz N, Sethi T, Silverman EK, Skopac J, Svab I, Trujillo S, Valentine JE, Verma D, West BJ, Vasudevan S. Recent Advances in Systems and Network Medicine: Meeting Report from the First International Conference in Systems and Network Medicine. Syst Med (New Rochelle). 2020; 3(1):22-35. PMID: 32226924; PMCID: PMC7099876.
    Citations: 2     
  69. Maron BA, Leopold JA, Hemnes AR. Metabolic syndrome, neurohumoral modulation, and pulmonary arterial hypertension. Br J Pharmacol. 2020 04; 177(7):1457-1471. PMID: 31881099.
    Citations: 9     Fields:    Translation:Humans
  70. Frid MG, McKeon BA, Thurman JM, Maron BA, Li M, Zhang H, Kumar S, Sullivan T, Laskowsky J, Fini MA, Hu S, Tuder RM, Gandjeva A, Wilkins MR, Rhodes CJ, Ghataorhe P, Leopold JA, Wang RS, Holers VM, Stenmark KR. Immunoglobulin-driven Complement Activation Regulates Proinflammatory Remodeling in Pulmonary Hypertension. Am J Respir Crit Care Med. 2020 01 15; 201(2):224-239. PMID: 31545648; PMCID: PMC6961733.
    Citations: 26     Fields:    Translation:HumansAnimalsCells
  71. Leopold JA, Maron BA, Loscalzo J. The application of big data to cardiovascular disease: paths to precision medicine. J Clin Invest. 2020 01 02; 130(1):29-38. PMID: 31895052; PMCID: PMC6934200.
    Citations: 21     Fields:    Translation:Humans
  72. Samokhin AO, Hsu S, Yu PB, Waxman AB, Alba GA, Wertheim BM, Hopkins CD, Bowman F, Channick RN, Nikolic I, Faria-Urbina M, Hassoun PM, Leopold JA, Tedford RJ, Ventetuolo CE, Leary PJ, Maron BA. Circulating NEDD9 is increased in pulmonary arterial hypertension: A multicenter, retrospective analysis. J Heart Lung Transplant. 2020 04; 39(4):289-299. PMID: 31952977.
    Citations: 8     Fields:    Translation:HumansCells
  73. Ruopp NF, Maron BA. Pulmonary arterial hypertension in the modern era: The intersection of genotype and phenotype. J Heart Lung Transplant. 2020 02; 39(2):113-114. PMID: 31759852.
    Citations: 1     Fields:    Translation:Humans
  74. Huston JH, Maron BA, French J, Huang S, Thayer T, Farber-Eger EH, Wells QS, Choudhary G, Hemnes AR, Brittain EL. Association of Mild Echocardiographic Pulmonary Hypertension With Mortality and Right Ventricular Function. JAMA Cardiol. 2019 11 01; 4(11):1112-1121. PMID: 31532457.
    Citations: 23     Fields:    Translation:Humans
  75. Crawford TC, Leary PJ, Fraser CD, Suarez-Pierre A, Magruder JT, Baumgartner WA, Zehr KJ, Whitman GJ, Masri SC, Sheikh F, De Marco T, Maron BA, Sharma K, Gilotra NA, Russell SD, Houston BA, Ramu B, Tedford RJ. Impact of the New Pulmonary Hypertension Definition on Heart Transplant Outcomes: Expanding the Hemodynamic Risk Profile. Chest. 2020 01; 157(1):151-161. PMID: 31446063.
    Citations: 7     Fields:    Translation:Humans
  76. Kovacs G, Douschan P, Maron BA, Condliffe R, Olschewski H. Mildly increased pulmonary arterial pressure: a new disease entity or just a marker of poor prognosis? Eur J Heart Fail. 2019 Sep; 21(9):1057-1061. PMID: 31407852.
    Citations: 2     Fields:    Translation:Humans
  77. Leary PJ, Jenny NS, Bluemke DA, Kawut SM, Kronmal RA, Lima JA, Maron BA, Ralph DD, Rayner SG, Ryan JJ, Steinberg ZL, Hinckley Stukovsky KD, Tedford RJ. Endothelin-1, cardiac morphology, and heart failure: the MESA angiogenesis study. J Heart Lung Transplant. 2020 01; 39(1):45-52. PMID: 31515065; PMCID: PMC6942224.
    Citations: 2     Fields:    Translation:Humans
  78. Simon MA, Maron BA. Pulmonary Hypertension in Patients with Heart Failure with Preserved Ejection Fraction. Where to Draw the Line. Am J Respir Crit Care Med. 2019 08 01; 200(3):278-279. PMID: 31038986; PMCID: PMC6680312.
    Citations: 1     Fields:    Translation:Humans
  79. Gillmeyer KR, Lee KM, Shao Q, Miller DR, Maron BA, Klings ES, Rinne ST, Wiener RS. Multisystem Healthcare Use among U.S. Veterans with Pulmonary Hypertension. Ann Am Thorac Soc. 2019 08; 16(8):1072-1074. PMID: 31026406.
    Citations:    Fields:    Translation:Humans
  80. Maron BA, Choudhary G, Tedford RJ, Brittain E. Correspondence on the debate regarding the haemodynamic definition of pulmonary hypertension. Eur Respir J. 2019 Jun; 53(6). PMID: 31167886.
    Citations: 1     Fields:    Translation:Humans
  81. Maron BA, Wertheim BM. Toward Early Diagnosis of Pulmonary Hypertension: Lessons From Oz. J Am Coll Cardiol. 2019 06 04; 73(21):2673-2675. PMID: 31146811; PMCID: PMC6747056.
    Citations:    Fields:    Translation:Humans
  82. Maron BA. Back to the Future: Building Up the Case for Exploring Red Blood Cell Morphology in Pulmonary Arterial Hypertension. Ann Am Thorac Soc. 2019 May; 16(5):548-550. PMID: 31042093.
    Citations: 1     Fields:    Translation:HumansCells
  83. Maron BJ, Maron MS, Maron BA, Loscalzo J. Moving Beyond the Sarcomere to Explain Heterogeneity in Hypertrophic Cardiomyopathy: JACC Review Topic of the Week. J Am Coll Cardiol. 2019 04 23; 73(15):1978-1986. PMID: 31000001; PMCID: PMC6550351.
    Citations: 37     Fields:    Translation:HumansCells
  84. Maron BA, Ryan JJ. A Concerning Trend for Patients With Pulmonary Hypertension in the Era of Evidence-Based Medicine. Circulation. 2019 04 16; 139(16):1861-1864. PMID: 30986105.
    Citations: 10     Fields:    Translation:Humans
  85. Leopold JA, Maron BA. Precision Medicine in Pulmonary Arterial Hypertension. Circ Res. 2019 03 15; 124(6):832-833. PMID: 30870130; PMCID: PMC6419751.
    Citations: 4     Fields:    Translation:Humans
  86. Wertheim BM, Lin YD, Zhang YY, Samokhin AO, Alba GA, Arons E, Yu PB, Maron BA. Isolating pulmonary microvascular endothelial cells ex vivo: Implications for pulmonary arterial hypertension, and a caution on the use of commercial biomaterials. PLoS One. 2019; 14(2):e0211909. PMID: 30811450; PMCID: PMC6392245.
    Citations: 3     Fields:    Translation:HumansAnimalsCells
  87. Maron BA, Wilkins MR. TORward a Molecular Convergence Point in Pulmonary Arterial Hypertension With mTOR. JACC Basic Transl Sci. 2018 Dec; 3(6):763-765. PMID: 30623135; PMCID: PMC6315047.
    Citations:    
  88. Abman SH, Lovering AT, Maron BA. Pulmonary Vascular Disease across the Life Span: A Call for Bridging Pediatric and Adult Cardiopulmonary Research and Care. Am J Respir Crit Care Med. 2018 12 15; 198(12):1471-1473. PMID: 30020807; PMCID: PMC6298635.
    Citations: 1     Fields:    Translation:Humans
  89. Musri MM, Coll-Bonfill N, Maron BA, Peinado VI, Wang RS, Altirriba J, Blanco I, Oldham WM, Tura-Ceide O, García-Lucio J, de la Cruz-Thea B, Meister G, Loscalzo J, Barberà JA. MicroRNA Dysregulation in Pulmonary Arteries from Chronic Obstructive Pulmonary Disease. Relationships with Vascular Remodeling. Am J Respir Cell Mol Biol. 2018 10; 59(4):490-499. PMID: 29757677; PMCID: PMC6178157.
    Citations: 16     Fields:    Translation:HumansCells
  90. Kolte D, Lakshmanan S, Jankowich MD, Brittain EL, Maron BA, Choudhary G. Mild Pulmonary Hypertension Is Associated With Increased Mortality: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2018 09 18; 7(18):e009729. PMID: 30371195.
    Citations: 26     Fields:    Translation:Humans
  91. Agarwal MA, Shah M, Patel B, Nolan VG, Reed GL, Oudiz RJ, Choudhary G, Maron BA. Association between Pulmonary Hypertension and Clinical Outcomes in Hospitalized Patients with Sickle Cell Disease. Am J Respir Crit Care Med. 2018 08 15; 198(4):534-537. PMID: 29648884; PMCID: PMC6118030.
    Citations: 1     Fields:    Translation:Humans
  92. Leary PJ, Kolb TM, Maron BA, Tedford RJ, Zamanian RT. Reply: Can treprostinil-induced early gastrointestinal side effects serve as predictors of pulmonary arterial hypertension prognosis? Int J Cardiol. 2018 08 01; 264:188. PMID: 29776569.
    Citations:    Fields:    Translation:Humans
  93. Brittain EL, Thennapan T, Maron BA, Chan SY, Austin ED, Spiekerkoetter E, Bogaard HJ, Guignabert C, Paulin R, Machado RF, Yu PB. Update in Pulmonary Vascular Disease 2016 and 2017. Am J Respir Crit Care Med. 2018 07 01; 198(1):13-23. PMID: 29533671; PMCID: PMC6034126.
    Citations: 3     Fields:    Translation:Humans
  94. Leary PJ, Hess E, Barón AE, Branch KR, Choudhary G, Hough CL, Maron BA, Ralph DD, Ryan JJ, Tedford RJ, Weiss NS, Zamanian RT, Lahm T. H2 Receptor Antagonist Use and Mortality in Pulmonary Hypertension: Insight from the VA-CART Program. Am J Respir Crit Care Med. 2018 06 15; 197(12):1638-1641. PMID: 29437490; PMCID: PMC6006405.
    Citations: 6     Fields:    Translation:Humans
  95. Samokhin AO, Stephens T, Wertheim BM, Wang RS, Vargas SO, Yung LM, Cao M, Brown M, Arons E, Dieffenbach PB, Fewell JG, Matar M, Bowman FP, Haley KJ, Alba GA, Marino SM, Kumar R, Rosas IO, Waxman AB, Oldham WM, Khanna D, Graham BB, Seo S, Gladyshev VN, Yu PB, Fredenburgh LE, Loscalzo J, Leopold JA, Maron BA. NEDD9 targets COL3A1 to promote endothelial fibrosis and pulmonary arterial hypertension. Sci Transl Med. 2018 06 13; 10(445). PMID: 29899023.
    Citations: 47     Fields:    Translation:HumansAnimalsCells
  96. Leary PJ, Maron BA, Tedford RJ, Lahm T. Pulmonary Hypertension: Good Intentions, But a Questionable Approach. Ann Am Thorac Soc. 2018 06; 15(6):664-666. PMID: 29856254.
    Citations: 2     Fields:    Translation:Humans
  97. Agarwal S, Spiekerkoetter E, Austin ED, de Jesus Perez V, Dezfulian C, Maron BA, Ryan JJ, Starks MA, Yu PB, Bonnet S, Perman SM. Career Development of Young Physician-Scientists in the Cardiovascular Sciences: Perspective and Advice From the Early Career Committee of the Cardiopulmonary, Critical Care, and Resuscitation Council of the American Heart Association. Circ Res. 2018 05 11; 122(10):1330-1333. PMID: 29748361; PMCID: PMC5972553.
    Citations: 4     Fields:    Translation:Humans
  98. Carroll BJ, Steigner ML, Priya S, Bhatt DL, Maron BA. Segmental Arterial Mediolysis: An Important but Often Overlooked Cause of Multi-Vessel Thrombosis. Am J Med. 2018 06; 131(6):e231-e234. PMID: 29505754.
    Citations: 1     Fields:    Translation:Humans
  99. Maron BA, Wertheim BM, Gladwin MT. Under Pressure to Clarify Pulmonary Hypertension Clinical Risk. Am J Respir Crit Care Med. 2018 02 15; 197(4):423-426. PMID: 29216444; PMCID: PMC5821912.
    Citations: 5     Fields:    Translation:Humans
  100. Oldham WM, Oliveira RKF, Wang RS, Opotowsky AR, Rubins DM, Hainer J, Wertheim BM, Alba GA, Choudhary G, Tornyos A, MacRae CA, Loscalzo J, Leopold JA, Waxman AB, Olschewski H, Kovacs G, Systrom DM, Maron BA. Network Analysis to Risk Stratify Patients With Exercise Intolerance. Circ Res. 2018 03 16; 122(6):864-876. PMID: 29437835; PMCID: PMC5924425.
    Citations: 22     Fields:    Translation:Humans
  101. Wang RS, Oldham WM, Maron BA, Loscalzo J. Systems Biology Approaches to Redox Metabolism in Stress and Disease States. Antioxid Redox Signal. 2018 10 01; 29(10):953-972. PMID: 29121773; PMCID: PMC6104248.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  102. Maron BA, Brittain EL, Choudhary G, Gladwin MT. Redefining pulmonary hypertension. Lancet Respir Med. 2018 03; 6(3):168-170. PMID: 29269004.
    Citations: 22     Fields:    Translation:Humans
  103. Assad TR, Maron BA, Robbins IM, Xu M, Huang S, Harrell FE, Farber-Eger EH, Wells QS, Choudhary G, Hemnes AR, Brittain EL. Prognostic Effect and Longitudinal Hemodynamic Assessment of Borderline Pulmonary Hypertension. JAMA Cardiol. 2017 12 01; 2(12):1361-1368. PMID: 29071338; PMCID: PMC5814998.
    Citations: 49     Fields:    Translation:Humans
  104. Ventetuolo CE, Hess E, Austin ED, Barón AE, Klinger JR, Lahm T, Maddox TM, Plomondon ME, Thompson L, Zamanian RT, Choudhary G, Maron BA. Sex-based differences in veterans with pulmonary hypertension: Results from the veterans affairs-clinical assessment reporting and tracking database. PLoS One. 2017; 12(11):e0187734. PMID: 29121097.
    Citations: 12     Fields:    Translation:Humans
  105. Hemnes AR, Beck GJ, Newman JH, Abidov A, Aldred MA, Barnard J, Berman Rosenzweig E, Borlaug BA, Chung WK, Comhair SAA, Erzurum SC, Frantz RP, Gray MP, Grunig G, Hassoun PM, Hill NS, Horn EM, Hu B, Lempel JK, Maron BA, Mathai SC, Olman MA, Rischard FP, Systrom DM, Tang WHW, Waxman AB, Xiao L, Yuan JX, Leopold JA. PVDOMICS: A Multi-Center Study to Improve Understanding of Pulmonary Vascular Disease Through Phenomics. Circ Res. 2017 10 27; 121(10):1136-1139. PMID: 29074534; PMCID: PMC5685561.
    Citations: 47     Fields:    Translation:HumansCTClinical Trials
  106. Opotowsky AR, Hess E, Maron BA, Brittain EL, Barón AE, Maddox TM, Alshawabkeh LI, Wertheim BM, Xu M, Assad TR, Rich JD, Choudhary G, Tedford RJ. Thermodilution vs Estimated Fick Cardiac Output Measurement in Clinical Practice: An Analysis of Mortality From the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program and Vanderbilt University. JAMA Cardiol. 2017 10 01; 2(10):1090-1099. PMID: 28877293.
    Citations: 22     Fields:    Translation:Humans
  107. van Riel ACMJ, Systrom DM, Oliveira RKF, Landzberg MJ, Mulder BJM, Bouma BJ, Maron BA, Shah AM, Waxman AB, Opotowsky AR. Hemodynamic and metabolic characteristics associated with development of a right ventricular outflow tract pressure gradient during upright exercise. PLoS One. 2017; 12(6):e0179053. PMID: 28636647.
    Citations:    Fields:    Translation:Humans
  108. Oliveira RKF, Faria-Urbina M, Maron BA, Santos M, Waxman AB, Systrom DM. Functional impact of exercise pulmonary hypertension in patients with borderline resting pulmonary arterial pressure. Pulm Circ. 2017 Jul-Sep; 7(3):654-665. PMID: 28895507; PMCID: PMC5841910.
    Citations: 13     
  109. Leary PJ, Kang S, Kolb TM, Maron BA, Ralph DD, Rao Y, Tedford RJ, Zamanian RT. What's in a side effect? The association between pulmonary vasodilator adverse drug events and clinical outcomes in patients with pulmonary arterial hypertension. Int J Cardiol. 2017 Aug 01; 240:386-391. PMID: 28412029.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  110. Covella M, Rowin EJ, Hill NS, Preston IR, Milan A, Opotowsky AR, Maron BJ, Maron MS, Maron BA. Mechanism of Progressive Heart Failure and Significance of Pulmonary Hypertension in Obstructive Hypertrophic Cardiomyopathy. Circ Heart Fail. 2017 Apr; 10(4):e003689. PMID: 28396501.
    Citations: 16     Fields:    Translation:Humans
  111. Metkus TS, Tampakakis E, Mullin CJ, Houston BA, Kolb TM, Mathai SC, Damico R, Maron BA, Hassoun PM, Brower RG, Tedford RJ. Pulmonary Arterial Compliance in Acute Respiratory Distress Syndrome: Clinical Determinants and Association With Outcome From the Fluid and Catheter Treatment Trial Cohort. Crit Care Med. 2017 03; 45(3):422-429. PMID: 27941369; PMCID: PMC5315617.
    Citations: 7     Fields:    Translation:Humans
  112. van Riel AC, Systrom DM, Oliveira RK, Landzberg MJ, Mulder BJ, Bouma BJ, Maron BA, Shah AM, Waxman AB, Opotowsky AR. Development of a Right Ventricular Outflow Tract Gradient During Upright Exercise: A Hemodynamic Observation. J Am Coll Cardiol. 2017 02 07; 69(5):595-597. PMID: 28153114; PMCID: PMC5813834.
    Citations: 2     Fields:    Translation:Humans
  113. Maron BA, Abman SH. Translational Advances in the Field of Pulmonary Hypertension. Focusing on Developmental Origins and Disease Inception for the Prevention of Pulmonary Hypertension. Am J Respir Crit Care Med. 2017 02 01; 195(3):292-301. PMID: 27854133; PMCID: PMC5328180.
    Citations: 29     Fields:    Translation:Humans
  114. Maron BA, Ryan JJ. Treatment differences in pulmonary arterial hypertension management. Pulm Circ. 2016 Dec; 6(4):619. PMID: 28090308; PMCID: PMC5210068.
    Citations: 3     
  115. Maron BA, Machado RF, Shimoda L. Pulmonary vascular and ventricular dysfunction in the susceptible patient (2015 Grover Conference series). Pulm Circ. 2016 Dec; 6(4):426-438. PMID: 28090285; PMCID: PMC5210067.
    Citations: 4     
  116. Maron BA, Galiè N. Diagnosis, Treatment, and Clinical Management of Pulmonary Arterial Hypertension in the Contemporary Era: A Review. JAMA Cardiol. 2016 Dec 01; 1(9):1056-1065. PMID: 27851839; PMCID: PMC5177491.
    Citations: 46     Fields:    
  117. Maron BA, Leopold JA. Systems biology: An emerging strategy for discovering novel pathogenetic mechanisms that promote cardiovascular disease. Glob Cardiol Sci Pract. 2016 Sep 30; 2016(3):e201627. PMID: 29043273; PMCID: PMC5642838.
    Citations: 3     
  118. Manrai AK, Funke BH, Rehm HL, Olesen MS, Maron BA, Szolovits P, Margulies DM, Loscalzo J, Kohane IS. Genetic Misdiagnoses and the Potential for Health Disparities. N Engl J Med. 2016 Aug 18; 375(7):655-65. PMID: 27532831; PMCID: PMC5292722.
    Citations: 255     Fields:    Translation:Humans
  119. Maron BJ, Maron BA. Revisiting Athlete's Heart Versus Pathologic Hypertrophy: ARVC and the Right Ventricle. JACC Cardiovasc Imaging. 2017 04; 10(4):394-397. PMID: 27544897.
    Citations: 5     Fields:    Translation:Humans
  120. Maron BA, Gladwin MT, Simon MA. Update in Pulmonary Vascular Disease 2015. Am J Respir Crit Care Med. 2016 06 15; 193(12):1337-44. PMID: 27304242; PMCID: PMC4910895.
    Citations: 2     Fields:    Translation:Humans
  121. Leopold JA, Maron BA. Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension. Int J Mol Sci. 2016 May 18; 17(5). PMID: 27213345.
    Citations: 46     Fields:    Translation:HumansCells
  122. Maron BA. Independence Day: Separating Right Ventricular Function From Pulmonary Arterial Hypertension in Systemic Sclerosis. Circulation. 2016 Jun 14; 133(24):2345-7. PMID: 27169738; PMCID: PMC4928682.
    Citations: 2     Fields:    Translation:Humans
  123. Aguero J, Ishikawa K, Hadri L, Santos-Gallego CG, Fish KM, Kohlbrenner E, Hammoudi N, Kho C, Lee A, Ibáñez B, García-Alvarez A, Zsebo K, Maron BA, Plataki M, Fuster V, Leopold JA, Hajjar RJ. Intratracheal Gene Delivery of SERCA2a Ameliorates Chronic Post-Capillary Pulmonary Hypertension: A Large Animal Model. J Am Coll Cardiol. 2016 05 03; 67(17):2032-46. PMID: 27126531; PMCID: PMC6019268.
    Citations: 30     Fields:    Translation:AnimalsCells
  124. Zonfrillo MR, Janigian NG, Maron BA. Death or Severe Injury at the Ball Game. Curr Sports Med Rep. 2016 May-Jun; 15(3):132-3. PMID: 27172075.
    Citations:    Fields:    Translation:Humans
  125. Aghamohammadzadeh R, Zhang YY, Stephens TE, Arons E, Zaman P, Polach KJ, Matar M, Yung LM, Yu PB, Bowman FP, Opotowsky AR, Waxman AB, Loscalzo J, Leopold JA, Maron BA. Up-regulation of the mammalian target of rapamycin complex 1 subunit Raptor by aldosterone induces abnormal pulmonary artery smooth muscle cell survival patterns to promote pulmonary arterial hypertension. FASEB J. 2016 07; 30(7):2511-27. PMID: 27006450; PMCID: PMC4904292.
    Citations: 26     Fields:    Translation:HumansAnimalsCells
  126. Kalra A, Harris KM, Maron BA, Maron MS, Garberich RF, Haas TS, Lesser JR, Maron BJ. Relation of Doppler Tissue Imaging Parameters With Heart Failure Progression in Hypertrophic Cardiomyopathy. Am J Cardiol. 2016 06 01; 117(11):1808-14. PMID: 27089980.
    Citations: 4     Fields:    Translation:Humans
  127. Maron BA. The quest for biomarker discovery in pulmonary arterial hypertension: the right takes lessons from the left. Heart. 2016 Mar; 102(5):335-6. PMID: 26869633; PMCID: PMC4758692.
    Citations:    Fields:    Translation:Humans
  128. Maron BA, Hess E, Maddox TM, Opotowsky AR, Tedford RJ, Lahm T, Joynt KE, Kass DJ, Stephens T, Stanislawski MA, Swenson ER, Goldstein RH, Leopold JA, Zamanian RT, Elwing JM, Plomondon ME, Grunwald GK, Barón AE, Rumsfeld JS, Choudhary G. Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. Circulation. 2016 Mar 29; 133(13):1240-8. PMID: 26873944; PMCID: PMC4811678.
    Citations: 109     Fields:    Translation:Humans
  129. Berry NC, Manyoo A, Oldham WM, Stephens TE, Goldstein RH, Waxman AB, Tracy JA, Leary PJ, Leopold JA, Kinlay S, Opotowsky AR, Systrom DM, Maron BA. Protocol for exercise hemodynamic assessment: performing an invasive cardiopulmonary exercise test in clinical practice. Pulm Circ. 2015 Dec; 5(4):610-8. PMID: 26697168; PMCID: PMC4671735.
    Citations: 22     
  130. Maron BA, Stephens TE, Farrell LA, Oldham WM, Loscalzo J, Leopold JA, Lewis GD. Elevated pulmonary arterial and systemic plasma aldosterone levels associate with impaired cardiac reserve capacity during exercise in left ventricular systolic heart failure patients: A pilot study. J Heart Lung Transplant. 2016 Mar; 35(3):342-351. PMID: 26586488; PMCID: PMC4789151.
    Citations: 5     Fields:    Translation:Humans
  131. Maron BA, Leopold JA. Emerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial Hypertension. Circulation. 2015 Jun 09; 131(23):2079-91. PMID: 26056345; PMCID: PMC4465126.
    Citations: 38     Fields:    Translation:HumansCells
  132. Wang RS, Maron BA, Loscalzo J. Systems medicine: evolution of systems biology from bench to bedside. Wiley Interdiscip Rev Syst Biol Med. 2015 Jul-Aug; 7(4):141-61. PMID: 25891169.
    Citations: 28     Fields:    Translation:Humans
  133. Steiner J, Wu WC, Jankowich M, Maron BA, Sharma S, Choudhary G. Echocardiographic predictors of mortality in patients with pulmonary hypertension and cardiopulmonary comorbidities. PLoS One. 2015; 10(3):e0119277. PMID: 25774911.
    Citations: 9     Fields:    Translation:Humans
  134. Ryan JJ, Rich JD, Maron BA. Building the case for novel clinical trials in pulmonary arterial hypertension. Circ Cardiovasc Qual Outcomes. 2015 Jan; 8(1):114-23. PMID: 25604559.
    Citations: 10     Fields:    Translation:Humans
  135. Dudzinski DM, Bhatt DL, Aragam JR, Maron BA. Explaining unexplained dyspnea: the ever "holesome" heart. Circulation. 2014 Dec 02; 130(23):2057-66. PMID: 25446059; PMCID: PMC4255914.
    Citations: 2     Fields:    Translation:Humans
  136. Maron BA. Emerging hemodynamic signatures of the right heart (Third International Right Heart Failure Summit, part 2). Pulm Circ. 2014 Dec; 4(4):705-16. PMID: 25610606; PMCID: PMC4278630.
    Citations: 1     
  137. Leopold JA, Maron BA. New thematic series: recent advances in pulmonary hypertension. Circulation. 2014 Nov 11; 130(20):1771. PMID: 25385935.
    Citations:    
  138. Maron BA. Hemodynamics should be the primary approach to diagnosing, following, and managing pulmonary arterial hypertension. Can J Cardiol. 2015 Apr; 31(4):515-20. PMID: 25742869.
    Citations: 3     Fields:    Translation:Humans
  139. Ryan JJ, Butrous G, Maron BA. The heterogeneity of clinical practice patterns among an international cohort of pulmonary arterial hypertension experts. Pulm Circ. 2014 Sep; 4(3):441-51. PMID: 25621157; PMCID: PMC4278603.
    Citations: 20     
  140. Maron BA, Leopold JA. The role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series). Pulm Circ. 2014 Jun; 4(2):200-10. PMID: 25006439.
    Citations: 45     
  141. Nayor M, Maron BA. Contemporary approach to paradoxical embolism. Circulation. 2014 May 06; 129(18):1892-7. PMID: 24799505; PMCID: PMC4053687.
    Citations: 4     Fields:    Translation:Humans
  142. Maron BA, Oldham WM, Chan SY, Vargas SO, Arons E, Zhang YY, Loscalzo J, Leopold JA. Upregulation of steroidogenic acute regulatory protein by hypoxia stimulates aldosterone synthesis in pulmonary artery endothelial cells to promote pulmonary vascular fibrosis. Circulation. 2014 Jul 08; 130(2):168-79. PMID: 25001622; PMCID: PMC4090713.
    Citations: 32     Fields:    Translation:HumansAnimalsCells
  143. Maron BA, Goldstein RH, Rounds SI, Shapiro S, Jankowich M, Garshick E, Moy ML, Gagnon D, Choudhary G. Study design and rationale for investigating phosphodiesterase type 5 inhibition for the treatment of pulmonary hypertension due to chronic obstructive lung disease: the TADA-PHiLD (TADAlafil for Pulmonary Hypertension associated with chronic obstructive Lung Disease) trial. Pulm Circ. 2013 Dec; 3(4):889-97. PMID: 25006405.
    Citations: 4     
  144. Opotowsky AR, Santos M, Maron BA, Afilalo J, Waxman AB, Landzberg MJ, Forfia PR. Towards widespread noninvasive assessment of pulmonary vascular resistance in clinical practice. J Am Soc Echocardiogr. 2014 Jan; 27(1):108-9. PMID: 24280251.
    Citations: 1     Fields:    Translation:Humans
  145. Yin T, Bader AR, Hou TK, Maron BA, Kao DD, Qian R, Kohane DS, Handy DE, Loscalzo J, Zhang YY. SDF-1a in glycan nanoparticles exhibits full activity and reduces pulmonary hypertension in rats. Biomacromolecules. 2013 Nov 11; 14(11):4009-20. PMID: 24059347.
    Citations: 10     Fields:    Translation:HumansAnimalsCells
  146. Maron BA, Choudhary G, Khan UA, Jankowich MD, McChesney H, Ferrazzani SJ, Gaddam S, Sharma S, Opotowsky AR, Bhatt DL, Rocco TP, Aragam JR. Clinical profile and underdiagnosis of pulmonary hypertension in US veteran patients. Circ Heart Fail. 2013 Sep 01; 6(5):906-12. PMID: 23811965.
    Citations: 30     Fields:    Translation:Humans
  147. Hadri L, Kratlian RG, Benard L, Maron BA, Dorfmüller P, Ladage D, Guignabert C, Ishikawa K, Aguero J, Ibanez B, Turnbull IC, Kohlbrenner E, Liang L, Zsebo K, Humbert M, Hulot JS, Kawase Y, Hajjar RJ, Leopold JA. Therapeutic efficacy of AAV1.SERCA2a in monocrotaline-induced pulmonary arterial hypertension. Circulation. 2013 Jul 30; 128(5):512-23. PMID: 23804254; PMCID: PMC3908449.
    Citations: 56     Fields:    Translation:HumansAnimalsCells
  148. Maron BA, Waxman AB, Opotowsky AR, Gillies H, Blair C, Aghamohammadzadeh R, Loscalzo J, Leopold JA. Effectiveness of spironolactone plus ambrisentan for treatment of pulmonary arterial hypertension (from the [ARIES] study 1 and 2 trials). Am J Cardiol. 2013 Sep 01; 112(5):720-5. PMID: 23751938; PMCID: PMC3906683.
    Citations: 36     Fields:    Translation:HumansCTClinical Trials
  149. Opotowsky AR, Clair M, Afilalo J, Landzberg MJ, Waxman AB, Moko L, Maron BA, Vaidya A, Forfia PR. A simple echocardiographic method to estimate pulmonary vascular resistance. Am J Cardiol. 2013 Sep 15; 112(6):873-82. PMID: 23735649; PMCID: PMC4317360.
    Citations: 18     Fields:    Translation:Humans
  150. Maron BA, Cockrill BA, Waxman AB, Systrom DM. The invasive cardiopulmonary exercise test. Circulation. 2013 Mar 12; 127(10):1157-64. PMID: 23479667.
    Citations: 47     Fields:    Translation:Humans
  151. Clarke JC, Aragam JR, Bhatt DL, Brown JD, Ferrazzani S, Pietro DA, Maron BA. An unusual cause of dyspnea diagnosed late in life: severe pulmonary hypertension resulting from isolated anomalous pulmonary venous connection. Circ Cardiovasc Imaging. 2013 Mar 01; 6(2):349-51. PMID: 23512781.
    Citations: 1     Fields:    Translation:Humans
  152. Maron BA, Loscalzo J. Pulmonary hypertension: pathophysiology and signaling pathways. Handb Exp Pharmacol. 2013; 218:31-58. PMID: 24092335.
    Citations: 13     Fields:    Translation:HumansAnimalsCells
  153. Maron BA. Targeting neurohumoral signaling to treat pulmonary hypertension: the right ventricle coming into focus. Circulation. 2012 Dec 11; 126(24):2806-8. PMID: 23124028.
    Citations: 3     Fields:    Translation:HumansAnimals
  154. Maron BA, Opotowsky AR, Landzberg MJ, Loscalzo J, Waxman AB, Leopold JA. Plasma aldosterone levels are elevated in patients with pulmonary arterial hypertension in the absence of left ventricular heart failure: a pilot study. Eur J Heart Fail. 2013 Mar; 15(3):277-83. PMID: 23111998.
    Citations: 51     Fields:    Translation:Humans
  155. Maron BA, Michel T. Subcellular localization of oxidants and redox modulation of endothelial nitric oxide synthase. Circ J. 2012; 76(11):2497-512. PMID: 23075817.
    Citations: 17     Fields:    Translation:HumansAnimalsCells
  156. Maron BA, Tang SS, Loscalzo J. S-nitrosothiols and the S-nitrosoproteome of the cardiovascular system. Antioxid Redox Signal. 2013 Jan 20; 18(3):270-87. PMID: 22770551.
    Citations: 32     Fields:    Translation:HumansAnimalsCells
  157. Maron BA, Zhang YY, White K, Chan SY, Handy DE, Mahoney CE, Loscalzo J, Leopold JA. Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension. Circulation. 2012 Aug 21; 126(8):963-74. PMID: 22787113; PMCID: PMC3534848.
    Citations: 73     Fields:    Translation:HumansAnimalsCells
  158. Maron BA, Bhatt DL, Nykiel M, Kinlay S, Waxman AB. Protocol for vasoreactivity testing with epoprostenol in pulmonary hypertension. Crit Pathw Cardiol. 2012 Mar; 11(1):40-2. PMID: 22337220.
    Citations: 3     Fields:    Translation:Humans
  159. Parikh VN, Jin RC, Rabello S, Gulbahce N, White K, Hale A, Cottrill KA, Shaik RS, Waxman AB, Zhang YY, Maron BA, Hartner JC, Fujiwara Y, Orkin SH, Haley KJ, Barabási AL, Loscalzo J, Chan SY. MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach. Circulation. 2012 Mar 27; 125(12):1520-32. PMID: 22371328; PMCID: PMC3353408.
    Citations: 135     Fields:    Translation:HumansAnimalsCells
  160. Maron BJ, Maron MS, Maron BA, Haas TS, Altman RK, Smalley SJ, Doerer JJ, Link MS, Mooney MR. Successful therapeutic hypothermia in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2011 Jun 14; 57(24):2454-6. PMID: 21640539.
    Citations:    Fields:    Translation:Humans
  161. Maron BA, Shekar PS, Goldhaber SZ. Paradoxical embolism. Circulation. 2010 Nov 09; 122(19):1968-72. PMID: 21060086.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  162. Maron BA, Leopold JA. Aldosterone receptor antagonists: effective but often forgotten. Circulation. 2010 Feb 23; 121(7):934-9. PMID: 20177008; PMCID: PMC2828634.
    Citations: 27     Fields:    Translation:Humans
  163. Maron BA, Goldhaber SZ, Sturzu AC, Rhee DK, Ali BS, Shah PB, Kirshenbaum JM. Catheter-directed thrombolysis for giant right atrial thrombus. Circ Cardiovasc Imaging. 2010 Jan; 3(1):126-7. PMID: 20086226.
    Citations:    Fields:    Translation:Humans
  164. Maron BA, Kolandaivelu K, Rhee DK, Bukhman AK, Edelman ER. Echocardiographic capture of right ventricular wall rupture during inferior wall acute myocardial infarction. Am J Cardiol. 2009 May 15; 103(10):1478-80. PMID: 19427450; PMCID: PMC6563804.
    Citations:    Fields:    Translation:Humans
  165. Maron BA, Zhang YY, Handy DE, Beuve A, Tang SS, Loscalzo J, Leopold JA. Aldosterone increases oxidant stress to impair guanylyl cyclase activity by cysteinyl thiol oxidation in vascular smooth muscle cells. J Biol Chem. 2009 Mar 20; 284(12):7665-72. PMID: 19141618.
    Citations: 45     Fields:    Translation:AnimalsCells
  166. Maron BA, Loscalzo J. The treatment of hyperhomocysteinemia. Annu Rev Med. 2009; 60:39-54. PMID: 18729731.
    Citations: 94     Fields:    Translation:Humans
  167. Maron BA, Leopold JA. Mineralocorticoid receptor antagonists and endothelial function. Curr Opin Investig Drugs. 2008 Sep; 9(9):963-9. PMID: 18729003.
    Citations: 5     Fields:    Translation:HumansAnimals
  168. Markert RJ, Rodenhauser P, El-Baghdadi MM, Juskaite K, Hillel AT, Maron BA. Personality as a prognostic factor for specialty choice: a prospective study of 4 medical school classes. Medscape J Med. 2008 Feb 27; 10(2):49. PMID: 18382718.
    Citations: 15     Fields:    Translation:Humans
  169. Maron BA, Loscalzo J. Should hyperhomocysteinemia be treated in patients with atherosclerotic disease? Curr Atheroscler Rep. 2007 Nov; 9(5):375-83. PMID: 18001620.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  170. Maron BA, Haas TS, Maron BJ. Sudden death from collapsing sand holes. N Engl J Med. 2007 Jun 21; 356(25):2655-6. PMID: 17582084.
    Citations: 1     Fields:    Translation:Humans
  171. de la Monte SM, Jhaveri A, Maron BA, Wands JR. Nitric oxide synthase 3-mediated neurodegeneration after intracerebral gene delivery. J Neuropathol Exp Neurol. 2007 Apr; 66(4):272-83. PMID: 17413318.
    Citations: 8     Fields:    Translation:HumansAnimals
  172. Leopold JA, Dam A, Maron BA, Scribner AW, Liao R, Handy DE, Stanton RC, Pitt B, Loscalzo J. Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity. Nat Med. 2007 Feb; 13(2):189-97. PMID: 17273168; PMCID: PMC3648863.
    Citations: 128     Fields:    Translation:HumansCells
  173. Maron BA, Fein S, Maron BJ, Hillel AT, El Baghdadi MM, Rodenhauser P. Ability of prospective assessment of personality profiles to predict the practice specialty of medical students. Proc (Bayl Univ Med Cent). 2007 Jan; 20(1):22-6. PMID: 17256038; PMCID: PMC1769529.
    Citations: 12     
  174. Maron BA, Loscalzo J. Homocysteine. Clin Lab Med. 2006 Sep; 26(3):591-609, vi. PMID: 16938586.
    Citations: 6     Fields:    Translation:HumansAnimals
  175. Maron BA, Dansereau LM, Maron BJ, Easton JD. Impact of postgraduate medical education on recognition of stroke. Cardiol Rev. 2005 Mar-Apr; 13(2):73-5. PMID: 15705256.
    Citations: 1     Fields:    Translation:Humans
  176. Maron BA, Maron BJ. Sudden death and other risks associated with dry-sand beach holes. JAMA. 2001 Apr 18; 285(15):1964. PMID: 11308431.
    Citations:    Fields:    
  177. Schwartz BD, Maron BA, Evans WJ, Winstead DK. Smooth pursuit tracking deficits of patients with schizophrenia at specific within-sine wave bins. Neuropsychiatry Neuropsychol Behav Neurol. 1999 Oct; 12(4):221-9. PMID: 10527106.
    Citations: 1     Fields:    Translation:Humans
  178. Schwartz BD, Maron BA, Evans WJ, Winstead DK. High velocity transient visual processing deficits diminish ability of patients with schizophrenia to recognize objects. Neuropsychiatry Neuropsychol Behav Neurol. 1999 Jul; 12(3):170-7. PMID: 10456801.
    Citations: 14     Fields:    Translation:Humans
  179. Brosius FC, Schwartz DE, Gleason WL, Maron B, Jones M, Roberts WC. Left atrial-to-right atrial shunt without atrial septal defect or precordial murmur. Pulmonary varix and hypertrophic cardiomyopathy. Chest. 1982 Jan; 81(1):91-4. PMID: 6459214.
    Citations:    Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Maron's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (483)
Explore
_
Co-Authors (87)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.